Page 12 - 103年度醫學倫理暨人文醫學讀書心得精選集
P. 12

bioengineering, nanotechnology, genetic engineering,
   bioagriculture and imaging technologies are starting to produce.
   When the boundaries of “science fiction” and “science” are
   getting vague, we seem getting power to change the living
   creatures as our willing. However, should we do something just
   because we can do it? Who gets access to these technologies,
   what people can choose to do with them, how business and
   governments around the world promote, regulate, pay for and
   prohibit them are among the biggest ethical challenges that
   face us in the years to come.

         As a doctor, the ethical dilemma I often face was the
   balance between quality and quantity of life.Technology has
   made it possible for seriously ill people to live far longer than
   they used to. But how should quality vs. quantity of life been
   weighed? What makes life worth living or who should make
   that decision for someone who cannot do so themselves? It is
   reflected in different attitudes towards rationing of expensive
   medical technologies and the efforts that comparably wealthy
   nations are willing to make to try and rescue children born with
   severe congenital disabilities or, elderly persons with
   demanding illnesses like Alzheimer's. I think the point of
   medicine is not to preserve biological life but to restore
   fundamental human capacities — cognition, emotion, mobility
   and human interactivity.

2 103 醫學倫理、人文醫學、心得
   7   8   9   10   11   12   13   14   15   16   17